Omega Healthcare Investors Inc
$ 48.46
-0.45%
07 Aug - close price
- Market Cap 15,284,054,000 USD
- Current Price $ 48.46
- High / Low $ 48.72 / 48.34
- Stock P/E 17.25
- Book Value 18.02
- EPS 2.81
- Next Earning Report -
- Dividend Per Share $2.69
- Dividend Yield 5.53 %
- Next Dividend Date 2026-08-14
- ROA 0.05 %
- ROE 0.16 %
- 52 Week High 51.69
- 52 Week Low 37.02
About
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily skilled nursing and assisted living facilities.
Analyst Target Price
$52.00
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-29 | 2026-04-28 | 2026-02-04 | 2025-10-30 | 2025-07-31 | 2025-05-01 | 2025-02-05 | 2024-10-30 | 2024-08-01 | 2024-05-02 | 2024-02-07 | 2023-11-02 |
| Reported EPS | 0.83 | 0.48 | 0.53 | 0.59 | 0.5 | 0.41 | 0.4 | 0.47 | 0.47 | 0.3 | 0.25 | 0.46 |
| Estimated EPS | 0.77 | 0.49 | 0.5 | 0.45 | 0.41 | 0.46 | 0.41 | 0.4 | 0.36 | 0.3 | 0.32 | 0.43 |
| Surprise | 0.06 | -0.01 | 0.03 | 0.14 | 0.09 | -0.05 | -0.01 | 0.07 | 0.11 | 0 | -0.07 | 0.03 |
| Surprise Percentage | 7.7922% | -2.0408% | 6% | 31.1111% | 21.9512% | -10.8696% | -2.439% | 17.5% | 30.5556% | 0% | -21.875% | 6.9767% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-08-14 | 2026-05-15 | 2026-02-17 | 2025-11-17 | 2025-08-15 | 2025-05-15 | 2025-02-18 | 2024-11-15 | 2024-08-15 | 2024-05-15 |
| Amount | $0.68 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 | $0.67 |
Next Dividend Records
| Dividend per share (year): | $2.69 |
| Dividend Yield | 5.53% |
| Next Dividend Date | 2026-08-14 |
| Ex-Dividend Date | 2026-08-03 |
Recent News: OHI
2026-08-08 23:41:55
This article provides key metrics for the OHI4479341 bond issued by Omega Healthcare Investors, Inc. The bond has a coupon rate of 4.75%, an issue date of April 4, 2017, and matures on January 15, 2028. Omega Healthcare Investors, Inc. finances and provides capital to the long-term healthcare industry, focusing on various types of care facilities.
2026-08-07 20:40:57
Omega Healthcare Investors, Inc.'s Chief Accounting Officer, Lucas M. Golem, has reported his initial beneficial ownership in the company. His holdings include 1,685 shares of common stock, 18,853 Profits Interest Units, and 31,738 OP Units, with specific vesting schedules for certain units. These disclosures provide transparency regarding a key executive's stake in the company, encompassing both direct stock ownership and various forms of equity interests tied to the operating partnership.
2026-08-07 03:41:31
This article provides a bond risk profile for OHI4479341, a bond issued by Omega Healthcare Investors, Inc. The profile highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating. It also mentions the availability of analyst ratings for bonds.
2026-08-06 18:40:57
RBC Capital has reiterated its Hold rating on Omega Healthcare Investors Inc (OHI.US) and increased its target price for the stock to $51. This indicates a continued neutral outlook with a slightly higher valuation expectation for the company.
2026-08-05 06:41:55
Amundi reduced its stake in Omega Healthcare Investors (OHI) by 51% in Q1 2026, selling over 585,000 shares and retaining a significant holding. Despite this, other institutional investors increased their positions, and the company reported strong Q2 earnings, beating analyst estimates and increasing its quarterly dividend. Analysts maintain a "Hold" rating with an average price target close to its current trading price.
2026-08-04 19:13:19
Omega Healthcare Investors Inc (OHI) saw its stock fall 3.2% on August 3, 2026, closing at $49.01. Despite this, GuruFocus's GF Value™ indicates the stock is 22.9% overvalued, with a fair value estimated at $39.89. The company has an "Above Average" GF Score™ of 75/100, highlighting solid fundamentals, but its financial strength is rated lower.
